Nivolumab Plus Ipilimumab in Thyroid Cancer | stella

Learn Data For Researchers Find trials matched to me

Learn Data For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Nivolumab Plus Ipilimumab in Thyroid Cancer | stella

Back to Thyroid Cancer trials

Completed

Plain-English translation of NCT03246958 on ClinicalTrials.gov ↗ · Source last updated June 2025 · How we translate trials

Read our Thyroid cancer research guide →

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

United States

Dana Farber Cancer Institute, Boston, Massachusetts

Results

Read the full plain-English summary of this trial →

Key details

Phase

Testing effectiveness

Sponsor

Dana-Farber Cancer Institute

Collaborators

Bristol-Myers Squibb

Enrollment target

~53 participants

Started

October 2017

Primary completion

January 2021

View full record on ClinicalTrials.gov

Age range

18 Years and older

Last updated on clinicaltrials.gov in June 2025.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.